Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings results on January 29, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $0.47, missing the consensus estimate of $0.55 by $0.08 per share. Revenue came in at $7.6B, missing the estimate of $8.5B.
Takeda Pharmaceutical's stock moved following the earnings release. The stock currently trades at $17.49 with a market capitalization of $45.4B.